Sign up to save your podcasts
Or
Share 30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 20 Safety Considerations Beyond the Lab (Societal and Ethical Implications)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 20 Safety Considerations Beyond the Lab (Societal and Ethical Implications)
This podcast episode explores the societal safety implications of cannabinoids and psychedelics, covering key topics like addiction potential, psychological risks, and substance misuse. The discussion examines how regulatory frameworks and quality control measures like cGMP compliance can help ensure public safety. The episode also delves into the FDA's role in drug approval, the importance of accurate labeling, and the broader ethical considerations of integrating these substances into mainstream use.
View all episodes
By Jim Mitchell and Google NotebookLMThis podcast episode explores the societal safety implications of cannabinoids and psychedelics, covering key topics like addiction potential, psychological risks, and substance misuse. The discussion examines how regulatory frameworks and quality control measures like cGMP compliance can help ensure public safety. The episode also delves into the FDA's role in drug approval, the importance of accurate labeling, and the broader ethical considerations of integrating these substances into mainstream use.